Related Experiment Video

Updated: Jun 21, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia:

Alain Stepanian1, Soraya Benchenni, Tiphaine Beillat-Lucas

  • 1AP-HP, Hôpital Louis Mourier, Service d'Hématologie Biologique, Colombes, France.

Plos One
|July 10, 2009
PubMed

Insights

Maternal CX3CR1 gene variants V249I and T280M are not associated with preeclampsia. However, soluble CX3CL1 levels may be elevated in preeclampsia patients, particularly in early-onset cases.

Area of Science:

  • Cardiovascular Biology
  • Reproductive Medicine
  • Immunogenetics

Background:

  • Preeclampsia and coronary artery disease share risk factors, indicating common inflammatory pathways.
  • The CX3CR1/CX3CL1 system influences leukocyte behavior and is implicated in inflammatory conditions.
  • Specific CX3CR1 variants (M280/I249) show atheroprotective effects and reduce endothelial dysfunction.

Purpose of the Study:

  • To investigate the association between CX3CR1 gene polymorphisms (V249I and T280M) and preeclampsia.
  • To examine the relationship between these polymorphisms and endothelial dysfunction in pregnant women.

Main Methods:

  • A case-control study involving 184 white women with preeclampsia and 184 matched controls.
  • Real-time polymerase chain reaction was used to analyze CX3CR1 polymorphisms.
  • Endothelial dysfunction biomarkers (von Willebrand factor, VCAM-1, thrombomodulin) and soluble CX3CL1 were quantified using ELISA.

Main Results:

  • No association was found between I249 and M280 alleles and preeclampsia or endothelial injury.
  • A trend towards increased soluble CX3CL1 levels was observed in preeclampsia patients.
  • Elevated CX3CL1 levels were more pronounced in early-onset preeclampsia compared to late-onset cases.

Conclusions:

  • Maternal CX3CR1 V249I and T280M polymorphisms do not appear to increase susceptibility to preeclampsia.
  • This is the first study to analyze these CX3CR1 polymorphisms in preeclampsia.
  • Further research is needed to clarify the role of soluble CX3CL1 in preeclampsia pathophysiology.
Abstract

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...